Avita Medical Inc. (RCEL) Stock Overview
Explore Avita Medical Inc.’s financial performance, market position, analyst ratings, and future outlook.
Avita Medical Inc. (RCEL)
Key Financials
Key Financials
Market Cap
287.7M
P/E Ratio
-7.83
EPS (TTM)
$-1.44
ROE
2.32%
RCEL Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Avita Medical Inc. (NASDAQ: RCEL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Avita Medical Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RCEL on the NASDAQ shows an RSI of 66.45, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.00 for the NASDAQ listing.
Key metrics behind Avita Medical Inc.'s NASDAQ-traded stock include a P/E ratio of -7.83 and a market capitalization of 287.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RCEL on the NASDAQ.